Date: 2011-10-31
Type of information: Company acquisition
Acquired company: Cobra Biologics (UK)
Acquiring company: Unitech Pharma Group (Sweden)
Amount:
Terms: Cobra Biologics, the international manufacturer of biopharmaceuticals, has announced as part of its strategy to expand its service offering the acquisition of Unitech Pharma Group and its bio-production facility in Matfors near Sundsvall, Sweden.
Under the terms of the agreement, Cobra Biologics will acquire 100% of the shareholding in Unitech Pharma Group, which provides a 600L clinical and commercial microbial GMP production capacity, commercial aseptic fill/finish and lyophilisation capability.
Cobra’s comprehensive service offering now includes cell line development, analytical and process development, GMP production, fill/finish, product release for Phase I, II, III clinical trials and in-market supply.
Details:
Related:
